All In Biotech

Free tool

FAERS Monitor: Pemfexy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209472 or its brand name (Pemfexy, Pemetrexed). Reports on generic versions are filed under their own applications.

Reports

22,312

Serious

21,864

98% of reports

Hospitalization

10,318

Death reported

3,879

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malignant neoplasm progression1,726
  • anaemia1,313
  • disease progression1,147
  • off label use1,130
  • nausea1,071
  • neutropenia1,071
  • diarrhoea1,041
  • pancytopenia1,010
  • thrombocytopenia997
  • drug ineffective983
  • acute kidney injury840
  • vomiting823
  • death803
  • pneumonia800
  • febrile neutropenia799

Reports by year received

View as table
YearReports
200436
200542
200617
200783
2008123
2009300
2010482
2011492
2012323
2013240
2014294
2015293
2016489
2017546
2018839
2019851
20201,050
20211,534
20222,220
20232,702
20243,452
20253,228
20262,676

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,031,847 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pancytopeniaSignal1,01017.316.315,287
malignant neoplasm progressionSignal1,72616.115.424,207
febrile neutropeniaSignal79911.510.77,566
disease progressionSignal1,1479.28.78,360
thrombocytopeniaSignal9978.58.06,538
neutropeniaSignal1,0717.57.15,993
anaemiaSignal1,3136.56.26,154
acute kidney injurySignal8405.24.92,848
pneumoniaSignal8002.32.2616
vomiting8231.71.5215
diarrhoea1,0411.51.4191
nausea1,0711.31.266
off label use1,1301.21.145
death8030.90.814
drug ineffective9830.70.7131

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.